Nutritional Supplement “Bao Khi Khang” as an Adjuvant Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

다국어 초록 (Multilingual Abstract)

To investigate the effectiveness of nutritional supplement Bao Khi Khang as an adjuvant therapy in acute exacerbations of chronic obstructive pulmonary disease (COPD) compared to conventional therapy alone. This was a prospective, randomized, open-label controlled trial in 60 patients presenting with acute exacerbation of COPD. Patients were randomized into two groups, the control and the experimental groups. The control group was treated with the standard therapeutic protocol (Antimicrobial+Corticosteroids+Bronchodilator+Mucolytic drugs). The experimental group was treated with Bao Khi Khang tablets combined with the standard therapeutic protocol. The treatment outcomes, including clinical and paraclinical parameters of exacerbation of COPD, were compared between the experimental group and the control group at day 15 and 30. This study was conducted according to protocol: 01.2014-HTNCKH. The results showed a significant reduction of major COPD exacerbation symptoms in experimental group. The favorable progresses in mMRC scale and COPD Assessment Test score before and after treatment, between experimental group and control group, were statistically different. Symptom control such as cough, copious sputum secretion, and bacterial infection was 90% effective (very good 50.0%, good 40.0%) in experimental group compared to 50% (very good 20%, good 30.0%) in control group. No adverse side effects were observed in experimental group. Bao Khi Khang nutritional supplement could be an effective and safe adjuvant therapy in acute exacerbations of COPD. Further interventional studies are required to confirm these findings.

참고문헌 (Reference)

1 Bestall JC, "Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease" 54 : 581-586, 1999

2 Ziegler D, "Treatment of symptomatic diabetic polyneuropathy with the antioxidant ${\alpha}$-lipoic acid: A meta-analysis" 21 : 114-121, 2004

3 Clarke R, "The viral mimic polyinosinic: Polycytidylic acid (Poly I:C) induces trpa1 channel hyper-responsiveness in an adult human stem cell-derived sensory neuronal model" 70 : A50-A51, 2015

4 Wedzicha JA, "The role of bronchodilator treatment in the prevention of exacerbations of COPD" 40 : 1545-1554, 2012

5 Cao X, "The free radical scavenger, ${\alpha}$-lipoic acid, protects against cerebral ischemia-reperfusion injury in gerbils" 23 : 365-370, 1995

6 Schols AM, "The 2014 ESPEN Arvid Wretlind Lecture: Metabolism & nutrition: Shifting paradigms in COPD management" 34 : 1074-1079, 2015

7 Zhao P, "Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD" 10 : 2633-2656, 2015

8 Hurst JR, "Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease" 173 : 71-78, 2006

9 He X, "Sophora flavescens Ait.: Traditional usage, phytochemistry and pharmacology of an important traditional Chinese medicine" 172 : 10-29, 2015

10 Soler-Cataluna JJ, "Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease" 60 : 925-931, 2005

11 Seemungal T, "Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease" 164 : 1618-1623, 2001

12 Biswas S, "Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease" 20 : 1496-1530, 2013

13 Rossman MJ, "Oxidative stress and COPD: The impact of oral antioxidants on skeletal muscle fatigue" 45 : 1235-, 2013

14 Maltais F, "Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD" 153 : 288-293, 1996

15 Hoang BX, "New approach in asthma treatment using excitatory modulator" 21 : 554-557, 2007

16 Ram A, "Medicinal plants useful for treating chronic obstructive pulmonary disease (COPD): Current status and future perspectives" 82 : 141-151, 2011

17 Borghi-Silva A, "L-carnitine as an ergogenic aid for patients with chronic obstructive pulmonary disease submitted to wholebody and respiratory muscle training programs" 39 : 465-474, 2006

18 Mukerji S, "Intravenous magnesium sulphate as an adjuvant therapy in acute exacerbations of chronic obstructive pulmonary disease: A single centre, randomised, double-blinded, parallel group, placebo-controlled trial: A pilot study" 128 : 34-42, 2015

19 Lim S, "Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: The EPIC Asia population-based survey" 14 : 4-, 2015

20 GOLD, "Global strategy for diagnosis managements and prevention of COPD, NHLBI/WHO"

21 Halbert RJ, "Global burden of COPD: Systematic review and meta-analysis" 28 : 523-532, 2006

22 Wen M-C, "Efficacy and tolerability of antiasthma herbal medicine intervention in adult patients with moderate-severe allergic asthma" 116 : 517-524, 2005

23 Jones PW, "Development and first validation of the COPD Assessment Test" 34 : 648-654, 2009

24 Akinbami LJ, "Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998-2009" 63 : 1-8, 2011

25 Elsammak M, "Carnitine deficiency in chronic obstructive pulmonary disease patients" 1 : 106-, 2011

26 Wedzicha JA, "COPD exacerbations: Defining their cause and prevention" 370 : 786-796, 2007

27 Kurmi OP, "COPD and chronic bronchitis risk of indoor air pollution from solid fuel: A systematic review and meta-analysis" 65 : 221-228, 2010

28 Tao J, "An integrated global chemomics and system biology approach to analyze the mechanisms of the traditional Chinese medicinal preparation Eriobotrya japonica-Fritillaria usuriensis dropping pills for pulmonary diseases" 16 : 4-, 2016

29 Verheij TJ, "Acute bronchitis: Aetiology, symptoms and treatment" 6 : 66-69, 1989

30 Barnes PJ, "ABC of chronic obstructive pulmonary disease. Future treatments" 333 : 246-248, 2006

31 Cadirci E, "${\alpha}$-lipoic acid as a potential target for the treatment of lung injury caused by cecal ligation and punctureinduced sepsis model in rats" 33 : 479-484, 2010